Color Genomics Sells $249 Breast Cancer Gene Test to Masses
Color Genomics is offering a $249 saliva test kit for women that will check for 19 genetic variants known to be correlated with a higher risk of breast cancer or ovarian cancer.
Source: Color Genomics via Bloomberg BusinessThis article is for subscribers only.
A Silicon Valley startup wants to make genetic testing for breast and ovarian cancer mutations available to the masses.
Color Genomics is offering a $249 saliva test kit for women that will check for variants in 19 genes known to be correlated with a higher risk of breast or ovarian cancer, including mutations in the BRCA1 gene, which led actress Angelina Jolie to choose a preventive double mastectomy. The test will be available online today.